Methods to Analyse Cost Data of Patients Who Withdraw in a Clinical Trial Setting

Author： Oostenbrink J.B.   Al M.J.   Mölken M.P.M.H.R-v.  

Publisher： Adis International

ISSN： 1170-7690

Source： PharmacoEconomics, Vol.21, Iss.15, 2003-01, pp. : 1103-1112

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cost Effectiveness of Angiotensin Receptor Blocker Monotherapy in Patients with Hypertension in the Netherlands: A Comparative Analysis Using Clinical Trial and Drug Utilization Data

By Boersma Cornelis  

American Journal of Cardiovascular Drugs, Vol. 10, Iss. 1, 2010-02 ,pp. : 49-54

Adis International

Access to resources Recommend Favorite

Alternative Views On Setting Clinical Trial Futility Criteria

By      

Journal of Biopharmaceutical Statistics, Vol. 24, Iss. 5, 2014-09 ,pp. : 976-993

Taylor & Francis Ltd

Access to resources Recommend Favorite

Paliperidone: A Review of Clinical Trial Data and Clinical Implications

By Wang Sheng-Min  

Clinical Drug Investigation, Vol. 32, Iss. 8, 2012-08 ,pp. : 497-512

Adis International

Access to resources Recommend Favorite

AbobotulinumtoxinA for Reduction of Glabellar Lines in Patients with Skin of Color: Post Hoc Analysis of Pooled Clinical Trial Data

By Taylor Susan C.   Callender Valerie D.   Albright Craig D.   Coleman Jeffrey   Axford-Gatley Robert A.   Lin Xiaoming  

Dermatologic Surgery, Vol. 38, Iss. 11, 2012-11 ,pp. : 1804-1811

Elsevier

Access to resources Recommend Favorite

Patient-Specific Dose Adjustment in the Cancer Clinical Trial Setting

By Rogatko André   Ghosh Pulak   Vidakovic Brani   Tighiouart Mourad  

Pharmaceutical Medicine, Vol. 22, Iss. 6, 2008-01 ,pp. : 345-350

Adis International

Access to resources Recommend Favorite